These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants. Beyer C; Cappetta K; Johnson JA; Bloch MH Depress Anxiety; 2017 Dec; 34(12):1134-1146. PubMed ID: 28881483 [TBL] [Abstract][Full Text] [Related]
4. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysis. Mills JA; Strawn JR J Am Acad Child Adolesc Psychiatry; 2020 Nov; 59(11):1240-1251. PubMed ID: 31682918 [TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and considerations for frailty. Mallery L; MacLeod T; Allen M; McLean-Veysey P; Rodney-Cail N; Bezanson E; Steeves B; LeBlanc C; Moorhouse P BMC Geriatr; 2019 Nov; 19(1):306. PubMed ID: 31718566 [TBL] [Abstract][Full Text] [Related]
11. Serotonin and norepinephrine reuptake inhibitors association with dry mouth in a hospital population. Katz J; Brooks S Quintessence Int; 2023 Feb; 54(2):150-154. PubMed ID: 36625886 [TBL] [Abstract][Full Text] [Related]
12. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram]. Favré P Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Nelson JC; Delucchi K; Schneider LS Am J Geriatr Psychiatry; 2008 Jul; 16(7):558-67. PubMed ID: 18591576 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of placebo group dropout in adult antidepressant trials. Li F; Nasir M; Olten B; Bloch MH Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 98():109777. PubMed ID: 31697973 [TBL] [Abstract][Full Text] [Related]
15. Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses. Roest AM; de Jonge P; Williams CD; de Vries YA; Schoevers RA; Turner EH JAMA Psychiatry; 2015 May; 72(5):500-10. PubMed ID: 25806940 [TBL] [Abstract][Full Text] [Related]
16. Treatment of depression--newer pharmacotherapies. Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454 [TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials. Carpenter DJ; Fong R; Kraus JE; Davies JT; Moore C; Thase ME J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354 [TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Second-Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression. Bali V; Holmes HM; Johnson ML; Chen H; Fleming ML; Aparasu RR Pharmacotherapy; 2016 Jan; 36(1):38-48. PubMed ID: 26748455 [TBL] [Abstract][Full Text] [Related]